JP2024016237A5 - - Google Patents

Download PDF

Info

Publication number
JP2024016237A5
JP2024016237A5 JP2023192683A JP2023192683A JP2024016237A5 JP 2024016237 A5 JP2024016237 A5 JP 2024016237A5 JP 2023192683 A JP2023192683 A JP 2023192683A JP 2023192683 A JP2023192683 A JP 2023192683A JP 2024016237 A5 JP2024016237 A5 JP 2024016237A5
Authority
JP
Japan
Prior art keywords
inhibitor
dose
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023192683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024016237A (ja
JP7811933B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/045195 external-priority patent/WO2019028367A1/en
Priority claimed from JP2020505844A external-priority patent/JP7417515B2/ja
Application filed filed Critical
Publication of JP2024016237A publication Critical patent/JP2024016237A/ja
Publication of JP2024016237A5 publication Critical patent/JP2024016237A5/ja
Application granted granted Critical
Publication of JP7811933B2 publication Critical patent/JP7811933B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023192683A 2017-08-04 2023-11-13 活動性好酸球性食道炎を治療する方法 Active JP7811933B2 (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762541242P 2017-08-04 2017-08-04
US62/541,242 2017-08-04
US201762561593P 2017-09-21 2017-09-21
US62/561,593 2017-09-21
EP18305252 2018-03-08
EP18305252.1 2018-03-08
PCT/US2018/045195 WO2019028367A1 (en) 2017-08-04 2018-08-03 METHODS OF TREATING ESOPHAGITIS WITH ACTIVE EOSINOPHILES
JP2020505844A JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020505844A Division JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法

Publications (3)

Publication Number Publication Date
JP2024016237A JP2024016237A (ja) 2024-02-06
JP2024016237A5 true JP2024016237A5 (https=) 2024-10-17
JP7811933B2 JP7811933B2 (ja) 2026-02-06

Family

ID=63113646

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020505844A Active JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法
JP2023192683A Active JP7811933B2 (ja) 2017-08-04 2023-11-13 活動性好酸球性食道炎を治療する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020505844A Active JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法

Country Status (9)

Country Link
EP (1) EP3661551A1 (https=)
JP (2) JP7417515B2 (https=)
KR (2) KR20240152980A (https=)
CN (1) CN111032084A (https=)
AU (2) AU2018311981B2 (https=)
CA (1) CA3071528A1 (https=)
IL (2) IL315556A (https=)
MA (1) MA49744A (https=)
MX (2) MX2020001305A (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4153300A1 (en) * 2020-05-22 2023-03-29 Regeneron Pharmaceuticals, Inc. Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor
GB202102277D0 (en) * 2021-02-18 2021-04-07 Nordic Bioscience As Immunoassay for detecting Eosinophilic Esophagitis
EP4091615A1 (en) * 2021-05-20 2022-11-23 Dr. Falk Pharma Gmbh Orodispersible effervescent tablet comprising budesonide for use in the treatment of eosinophilic esophagitis
WO2023208104A1 (zh) * 2022-04-29 2023-11-02 中山康方生物医药有限公司 抗人il-4ra的抗体及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI682781B (zh) * 2013-07-11 2020-01-21 美商再生元醫藥公司 藉由投與il-4r抑制劑治療嗜酸性食道炎的方法
AR098155A1 (es) * 2013-10-23 2016-05-04 Genentech Inc Métodos para diagnosticar y tratar trastornos eosinofílicos
KR20170123315A (ko) * 2015-03-11 2017-11-07 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Tslp 결합 단백질

Similar Documents

Publication Publication Date Title
JP2024016237A5 (https=)
JP2023520676A5 (https=)
CN105392497B (zh) 以il-4r抑制剂治疗嗜酸性食管炎的方法
Kim et al. Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases
JP2015527364A5 (https=)
RU2015109716A (ru) Способы лечения или предотвращения астмы посредством введения антагониста il-4r
JP2022169718A5 (https=)
JP2022543612A5 (https=)
JP2022160685A5 (https=)
JP2019531273A5 (https=)
JP2023515271A5 (https=)
RU2016101632A (ru) Способы лечения полипоза носа путем введения антагониста il-4r
JP2024174962A5 (https=)
JP2022526738A5 (https=)
JP2017535547A5 (https=)
JP2023527775A5 (https=)
JP2017036296A (ja) 抗il−5抗体を投与するための方法
JP2020500152A5 (https=)
RU2019111921A (ru) Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r
JP2019529560A5 (https=)
JP2024530954A5 (https=)
JP2021502349A5 (https=)
KR20140061403A (ko) 항―il―13 항체를 이용하여 천식을 치료하기 위한 방법 및 조성물
JP2021530438A5 (https=)
JP2020502261A5 (https=)